The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide
|出版商||Research Facts Ltd.||商品編碼||355213|
|全球前100家學名藥廠商 The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide|
|出版日期: 2016年03月28日||內容資訊: 英文||
These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide'.
There are many manufacturers of pharmaceuticals. This report profiles those with a focus on generics. These major companies have the experience, know-how and resources that enable them to identify patented products and make them available as a generic on the day of patent expiry. They manufacture multiple products in various dosage forms and in a wide variety of therapeutic classes and export them across the globe.
Profile information for each company in ‘The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide' typically includes:
Usage: competitive/financial analysis and strategic partner/alliance identification.
This report is perfect for suppliers of raw materials and equipment necessary for pharmaceutical production.
‘The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide' is ideal for distributors of pharmaceuticals to identify all of the leading manufacturers with the best products and the widest ranges.
Note: Most people will be aware of some of the major manufacturers of generic pharmaceuticals such as Krka, Lupin and Par Pharmaceutical but this report looks at all 100 of the top companies - companies like - Polpharma - Founded over 80 years ago, Polpharma is among the top 20 generic drug manufacturers in the world. The Company employs more than 7,500 people in Poland and in international markets. Polpharma has 7 manufacturing plants in Poland, Russia and Kazakhstan and 7 research and development centres. Polpharma's portfolio includes about 600 products and another 200 are being developed. The Company specialises in pharmaceutical preparations used in cardiology, gastroenterology and neurology. They actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia. Polpharma has sales of US$ 1 billion per year and is led by Maurice Chagnaud, CEO.
Research Facts is one of the world's leading companies in life sciences publishing. It has a large portfolio of best-selling reports spanning diagnostics, pharmaceuticals, biotechnology and medical devices. It's customers include most of the world's major companies in these sectors e.g. Abbott Laboratories, Alcon, Allergan, Aurobindo, Axis-Shield, Baxter, Bayer, B. Braun, BD, Biomet, Boehringer Ingelheim, CareFusion, Covance, Covidien, C.R. Bard, Edwards Lifesciences, Fresenius, GE Healthcare, Genzyme, HemoCue, Intuitive Surgical, Ipsen, Medtronic, Merit Medical Systems, Millipore, Mölnlycke Health Care, Novartis, Paul Hartmann, Philips Medical, Qiagen, Siemens Healthcare, Smith & Nephew, Synthes, Teleflex, Teva, Zentiva etc.. Research Facts also counts many multinational financial services, law and management consulting firms such as Bain & Company, McKinsey & Company and The Boston Consulting Group among its customers.
Research Facts currently has customers in some forty countries across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Mauritius, Netherlands, Pakistan, Peru, Portugal, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.
Research Facts' reports help you make informed decisions about the markets and organisations that affect your business.